Sign in to view content

A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma

Prithvi Mruthyunjaya, MD, MHS

Video
Published 2021

Related

Correlation of Cytogenetic Abnormalities with Clinical Features of Uveal Melanoma
Carol L. Shields, MD
Updates from the Field
2017
Post Hoc Analysis of Suprachoroidal Injection Experience Across Retinal Disease Indications
Christopher R Henry, MD
Annual Meeting Talks
2020
An analysis of the phase 2 trial with intraviteal aflibercept and suprachoroidal
Michael A. Singer, MD
Updates from the Field
2017

Category: Ocular Oncology

See more